Cambium Bio Ltd (CMB) — Cash Flow Quality Index
Cambium Bio Ltd (CMB) has a Cash Flow Quality Index of -0.82x as of March 2023. Operating cash flow of AU$-308.70K is below net income of AU$374.44K, suggesting accrual-heavy earnings not yet converted to cash. Explore how much of Cambium Bio Ltd's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cambium Bio Ltd Cash Flow Quality Index (1999–2021)
Historical Cash Flow Quality Index for Cambium Bio Ltd across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how tangible is Cambium Bio Ltd's equity to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Cambium Bio Ltd (1999–2021)
Year-by-year earnings quality comparison for Cambium Bio Ltd. For live market cap and the full company financial profile, see CMB market cap.
| Year | Quality Index | Operating CF (AUD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | 0.88x | AU$2.42 Million | AU$2.76 Million | ▼ -20.1% |
| 2017 | 1.10x | AU$3.59 Million | AU$3.27 Million | ▼ -41.5% |
| 2001 | 1.88x | AU$38.20 Million | AU$20.36 Million | ▲ +6.6% |
| 2000 | 1.76x | AU$48.26 Million | AU$27.42 Million | ▼ -20.8% |
| 1999 | 2.22x | AU$33.43 Million | AU$15.03 Million | — |